J
Johannes E. A. Wolff
Researcher at AbbVie
Publications - 194
Citations - 7302
Johannes E. A. Wolff is an academic researcher from AbbVie. The author has contributed to research in topics: Glioma & Choroid plexus. The author has an hindex of 43, co-authored 184 publications receiving 6621 citations. Previous affiliations of Johannes E. A. Wolff include Cleveland Clinic & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
Stefan Rutkowski,Udo Bode,Frank Deinlein,Holger Ottensmeier,Monika Warmuth-Metz,Niels Soerensen,Norbert Graf,Angela Emser,Torsten Pietsch,Johannes E. A. Wolff,Rolf D. Kortmann,Joachim Kuehl +11 more
TL;DR: Postoperative chemotherapy alone is a promising treatment for medulloblastoma in young children without metastases in children who have complete resection, residual tumor, and macroscopic metastases.
Journal ArticleDOI
Alex's Lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007-2011
Quinn T. Ostrom,Peter de Blank,Carol Kruchko,Claire M. Petersen,Peter Liao,Jonathan L. Finlay,Duncan Stearns,Johannes E. A. Wolff,Yingli Wolinsky,John J. Letterio,Jill S. Barnholtz-Sloan +10 more
TL;DR: The CBTRUS Statistical Report: Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011 comprehensively describes the current population-based incidence of primary malignant and non-malignant brain and CNS tumors in children ages 0–14 years.
Journal ArticleDOI
Choroid plexus tumours.
TL;DR: A thorough review of the medical literature revealed 566 well-documented choroid plexus tumours, which were entered into a database and found Histology was the most important prognostic factor, and Radiotherapy was associated with significantly better survival in choroids plexUS-carcinomas.
Journal ArticleDOI
American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom,Haley Gittleman,Peter de Blank,Jonathan L. Finlay,James G. Gurney,Roberta McKean-Cowdin,Duncan Stearns,Johannes E. A. Wolff,Max Liu,Yingli Wolinsky,Carol Kruchko,Jill S. Barnholtz-Sloan +11 more
TL;DR: This poster presents a poster presented at the 2015 American Academy of Neurological Surgeons annual conference on adolescent brain tumour research, entitled “Advances in Hematology-Oncology and BMT: Foundations of Pediatric Hematological and Oncology Research.”
Journal ArticleDOI
Postoperative Adjuvant Dendritic Cell ^ Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
Steven De Vleeschouwer,Steffen Fieuws,Stefan Rutkowski,Frank Van Calenbergh,Johannes van Loon,Jan Goffin,Raf Sciot,Guido Wilms,Philippe Demaerel,Monika Warmuth-Metz,Niels Soerensen,Johannes E. A. Wolff,Johannes E. A. Wolff,Sabine Wagner,Eckhart Kaempgen,Stefaan Van Gool +15 more
TL;DR: Adjuvant DC-based immunotherapy for patients with relapsed GBM is safe and can induce long-term survival and a trend to PFS improvement was shown in the faster vaccination schedule, which was observed in favor of the faster DC vaccination schedule with tumor lysate boosting.